ScholarIQanswers from OpenAlex & ORCID
Quan Sing Ng
ResearcherPublications, citations & collaboration network
Quan Sing Ng is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Quan Sing Ng have?
ScholarIQindexed works
Quan Sing Ng has 159 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Quan Sing Ng have?
ScholarIQcitation count
Quan Sing Ng has 2,909 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Quan Sing Ng?
ScholarIQh-index
Quan Sing Ng has an h-index of 28 in OpenAlex.
What is the i10-index of Quan Sing Ng?
ScholarIQi10-index
Quan Sing Ng has an i10-index of 52 in OpenAlex.
What is the ORCID of Quan Sing Ng?
ScholarIQorcid
The ORCID for Quan Sing Ng is on the source record.
What is the OpenAlex record for Quan Sing Ng?
ScholarIQopenalex
The OpenAlex for Quan Sing Ng is on the source record.
What are the most-cited papers on Quan Sing Ng?
ScholarIQmost cited works
Non–Small Cell Lung Cancer: Histopathologic Correlates for Texture Parameters at CT
Balaji Ganeshan, Vicky Goh, Henry Mandeville, Quan Sing Ng, Peter Hoskin, Kenneth A. Miles
Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): a randomised, double-blind, placebo-controlled, phase 3 trial
Matthew R. Smith, Chris Parker, Fred Saad, Kurt Miller, Bertrand Tombal, Quan Sing Ng, Martin Boegemann, Vsevolod Matveev, Josep M. Piulats, Luis Eduardo Rosa Zucca, Oleg Karyakin, Go Kimura, Nobuaki Matsubara, William Carlos Nahas, Franco Nolè, Eli Rosenbaum, Axel Heidenreich, Yoshiyuki Kakehi, Amily Zhang, Heiko Krissel, Michael Teufel, Junwu Shen, Volker Jean Wagner, Celestia S. Higano
Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost-effectiveness analysis
Aaron C. Tan, Gillianne Lai, Gek San Tan, Shou Yu Poon, Brett Doble, Tse Hui Lim, Zaw Win Aung, Angela Takano, Wan Ling Tan, Mei‐Kim Ang, Bien Soo Tan, Devanand Anantham, Chow Wei Too, Apoorva Gogna, Boon‐Hean Ong, Tina Koh, Ravindran Kanesvaran, Quan Sing Ng, Amit Jain, Tanujaa Rajasekaran, Alvin S.T. Lim, Wan Teck Lim, Chee‐Keong Toh, Eng-Huat Tan, Tony Kiat Hon Lim, Daniel S.W. Tan
Clonal <i>MET</i> Amplification as a Determinant of Tyrosine Kinase Inhibitor Resistance in Epidermal Growth Factor Receptor–Mutant Non–Small-Cell Lung Cancer
Gillianne Lai, Tse Hui Lim, John Lim, Perry J.R. Liew, Xue Lin Kwang, Rahul Nahar, Zaw Win Aung, Angela Takano, Yin Yeng Lee, Dawn Pingxi Lau, Gek San Tan, Sze Huey Tan, Wan Ling Tan, Mei‐Kim Ang, Chee‐Keong Toh, Bien Soo Tan, Devanand Anantham, Chow Wei Too, Apoorva Gogna, Boon Hean Ong, Tina Koh, Ravindran Kanesvaran, Quan Sing Ng, Amit Jain, Tanujaa Rajasekaran, Ju Yuan, Tony Kiat Hon Lim, Alvin S.T. Lim, Axel M. Hillmer, Wan Teck Lim, N. Gopalakrishna Iyer, Wai Leong Tam, Weiwei Zhai, Eng-Huat Tan, Daniel Shao-Weng Tan
Pembrolizumab monotherapy versus chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal cancer (KEYNOTE-122): an open-label, randomized, phase III trial
Anthony T.�C. Chan, V.H.F. Lee, R-L. Hong, M-J. Ahn, Wan Qin Chong, S. B. Kim, Gwo Fuang Ho, Priscilla B. Caguioa, Nuttapong Ngamphaiboon, Cheryl Ho, Mubashir Aziz, Quan Sing Ng, C-J. Yen, Nopadol Soparattanapaisarn, Roger KC Ngan, S.K. Kho, M.L.A. Tiambeng, Tak Yun, Virote Sriuranpong, Alain P. Algazi, Andy S. K. Cheng, Erminia Massarelli, Ramona F. Swaby, Sanatan Saraf, Jianda Yuan, Lillian L. Siu